Leukocyte telomere length and late-life depression

American Journal of Geriatric Psychiatry

Volumn 23, Issue 4, 2015, Pages 423-432

  Schaakxs, Roxanne ^a   Verhoeven, Josine E ^a   Oude Voshaar, Richard C ^b   Comijs, Hannie C ^a   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cellular aging; Late life depression; telomere length; telomere shortening

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ANXIETY DISORDER; APATHY; ARTICLE; BECK ANXIETY INVENTORY; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DSM-IV; FEMALE; GENE DOSAGE; HUMAN; LATE LIFE DEPRESSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; MINI MENTAL STATE EXAMINATION; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PRIMARY MEDICAL CARE; RESTRICTION FRAGMENT; RISK FACTOR; TELOMERE HOMEOSTASIS; TELOMERE LENGTH; CASE CONTROL STUDY; COMORBIDITY; DEPRESSIVE DISORDER; GENETICS; LATE ONSET DISORDER; MIDDLE AGED; NETHERLANDS; ONSET AGE; PATHOLOGY; PHYSIOLOGY; TELOMERE SHORTENING; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LATE ONSET DISORDERS; LEUKOCYTES; MALE; MIDDLE AGED; NETHERLANDS; TELOMERE SHORTENING;

EID: 84928065948     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2014.06.003     Document Type: Article

References (45)

1. World Health Organization: The global burden of disease. 2004 update; 2008. Available at: http://www.who.int/healthinfo/global-burden-disease/2004-report-update/en/. Accessed September 24, 2013
2. Penninx BW, Milaneschi Y, Lamers F, et al: Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013; 11:129
3. Cuijpers P, Vogelzangs N, Twisk J, et al: Comprehensive metaanalysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 2014; 171:453e462
4. Wolkowitz OM, Epel ES, Reus VI, et al: Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 2010; 27:327e338
5. Blackburn EH, Greider CW, Szostak JW: Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12:1133e1138
6. Olovnikov AM: Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 1996; 31:443e448
7. Blackburn EH: Switching and signaling at the telomere. Cell 2001; 106:661e673
8. Fitzpatrick AL, Kronmal RA, Gardner JP, et al: Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165:14e21
9. Martin-Ruiz C, Dickinson HO, Keys B, et al: Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006; 60:174e180
10. Benetos A, Okuda K, Lajemi M, et al: Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37:381e385
11. Willeit P, Willeit J, Mayr A, et al: Telomere length and risk of incident cancer and cancer mortality. JAMA 2010; 304:69e75
12. Simon NM, Smoller JW, McNamara KL, et al: Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60:432e435
13. Garcia-Rizo C, Fernandez-Egea E, Miller BJ, et al: Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naive patients with depression. Brain Behav Immun 2013; 28:49e53
14. Hartmann N, Boehner M, Groenen F, et al: Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 2010; 27:1111e1116
15. Lung FW, Chen NC, Shu BC: Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet 2007; 17:195e199
16. Wikgren M, Maripuu M, Karlsson T, et al: Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 2012; 71:294e300
17. WolkowitzOM, Mellon SH,Epel ES, et al: Leukocyte telomere length inmajor depression: correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS One 2011; 6:e17837
18. Verhoeven JE, R-ev-esz D, Epel ES, et al: Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry 2014; 19:895e901
19. Hoen PW, Rosmalen JG, Schoevers RA, et al: Association between anxiety but not depressive disorders and leukocyte telomere length after 2 years of follow-up in a population-based sample. Psychol Med 2013; 43:689e697
20. Malan S, Hemmings S, Kidd M, et al: Investigation of telomere length and psychological stress in rape victims. Depress Anxiety 2011; 28:1081e1085
21. Elvsashagen T, Vera E, Boen E, et al: The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord 2011; 135:43e50
22. Shaffer JA, Epel E, Kang MS, et al: Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based study. PLoS One 2012; 7:e48318
23. Phillips AC, Robertson T, Carroll D, et al: Do symptoms of depression predict telomere length? Evidence from the west of Scotland twenty-07 study. Psychosom Med 2013; 75:288e296
24. Huzen J, van der Harst P, de Boer RA, et al: Telomere length and psychological well-being in patients with chronic heart failure. Age Ageing 2010; 39:223e227
25. Rius-Ottenheim N, Houben JM, Kromhout D, et al: Telomere length and mental well-being in elderly men from the Netherlands and Greece. Behav Genet 2012; 42:278e286
26. Hoen PW, de Jonge P, Na BY, et al: Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study. Psychosom Med 2011; 73:541e547
27. Comijs HC, van Marwijk HW, van der Mast RC, et al: The Netherlands Study of Depression in Older Persons (NESDO): a prospective cohort study. BMC Res Notes 2011; 4:524
28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington DC, American Psychiatric Association, 2000
29. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189e198
30. Lin J, Epel E, Cheon J, et al: Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 2010; 352:71e80
31. Wittchen HU, Robins LN, Cottler LB, et al: Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 1991; 159:645e653
32. Wittchen HU: Reliability and validity studies of the WHOeComposite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994; 28:57e84
33. Rush AJ, Gullion CM, Basco MR, et al: The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26:477e486
34. Beck AT, Epstein N, Brown G, et al: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56:893e897
35. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4:134e139
36. WHO Collaboration Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) Classification System. Oslo, Norway, World Health Organization, 2007
37. De Graaf R, Bijl RV, Ten Have M, et al: Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord 2004; 82:461e467
38. Craig CL, Marshall AL, Sjostrom M, et al: International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35:1381e1395
39. Ainsworth BE, Haskell WL, Herrmann SD, et al: 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011; 43:1575e1581
40. Kriegsman DM, Penninx BW, van Eijk JT, et al: Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996; 49:1407e1417
41. Djernes JK: Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006; 113:372e387
42. Hegeman JM, Kok RM, van der Mast RC, et al: Phenomenology of depression in older compared with younger adults: meta-Analysis. Br J Psychiatry 2012; 200:275e281
43. Muezzinler A, Zaineddin AK, Brenner H: A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev 2013; 12:509e519
44. Wolkowitz OM, Mellon SH, Epel ES, et al: Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012; 17:164e172
45. Aviv A, Hunt SC, Lin J, et al: Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res 2011; 39:e134